People · Operator
Named in public records as an officer, director or promoter · active 2014–2024 · Medical Devices, Biotechnology, Other Technology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Tally Surgical, Inc. | — | Medical Devices | Series A | $11.6M | $38.8M | 2022 |
| Origin Endoscopy Inc. | — | Biotechnology | Seed | $2.3M | $10.0M | 2024 |
| Abaris Financial, Inc. | — | Other Technology | Pre-Seed | $700K | $10.6M | 2014 |
Jason Grimes at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Jason Grimes on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Jeremy Starkweather | 1 | 4 |
| Stavros Vizirgianakis | 1 | 3 |
| David Dreyer | 1 | 3 |
| Brian Stewart | 1 | 2 |
| John Wynne | 1 | 2 |
| Michael Freeman | 1 | 2 |
| Jason Ylizarde | 1 | 2 |
| Stephen Inacker | 1 | 1 |
| David A. Dreyer | 1 | 1 |
| Stephen A. Inacker | 1 | 1 |
| Adam Colombo | 1 | 1 |
| Nimish Shukia | 1 | 1 |
| Matthew Carey | 1 | 1 |
| Stephen Hoag | 1 | 1 |
| Nimish Shukla | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.